Artery Technology Company
USPTO PatentsView assignee record - 13 granted patents across 14 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H03K (Pulse Technique).
The verdict
According to USPTO PatentsView, Artery ranks #20,767 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 14 technology areas.
- #20,767
- of 49,997 US assignees by volume
- 45th percentile
- by Innovation Score (33.6/100)
- 13.2
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R20767 · Foreign Corporation #20,767 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 13 grants
- MID-PACK #20,767/49,997
- PHOTO-FINISH Armo Biosciences
- CPC-FOCUS H03K · 14 areas
- INNOV-THIN 33.6/100
- CLAIMS-RICH 13.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Armo Biosciences, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Artery’s 33.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Artery
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Artery Technology · this assignee 34
Artery Technology · this assignee
34 score
- Crystaphase Products · near 34
Crystaphase Products · near
34 score
- Daiwa Kasei Kogyo · near 34
Daiwa Kasei Kogyo · near
34 score
- Infectious Disease… · near 34
Infectious Disease… · near
34 score
- Pieris Pharmaceuticals · near 34
Pieris Pharmaceuticals · near
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Artery's Innovation Score is 33.6/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Artery?
Each dot is one of Artery’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Artery’s own 13.2 claims/patent is at or below the 13.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Artery's grants concentrate
Artery Technology Company is a focused PatentsView assignee: 14 CPC subclasses with 61.5% of grants classified under H03K (Pulse Technique). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2021. By volume, Artery sits between Armo Biosciences, Inc. and Atec International Team Co., Ltd..
Artery's three-year grant acceleration
Artery Technology Company shows 4 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Artery's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Armo Biosciences
Armo Biosciences, Inc.
13 patents
- Arnold Umformtech…
Arnold Umformtechnik GMBH & Co. KG
13 patents
- Aroma System S R L
Aroma System S.R.L.
13 patents
- Arrien Pharmaceut…
Arrien Pharmaceuticals LLC
13 patents
- Artskills
Artskills, Inc.
13 patents
- ASM Assembly Syst…
ASM Assembly Systems Singapore PTE. Ltd.
13 patents
- Asset Guard Produ…
Asset Guard Products Inc.
13 patents
- Atec Internationa…
Atec International Team Co., Ltd.
13 patents
- Artery Technology ◀
Artery Technology Company
13 patents
What this shows Artery holds 13 patents at rank #20,726, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Artery
By rank, the assignees closest to #20,726 in granted patent volume.
- Armo Biosciences, Inc. #20,722 · 13 patents
- Arnold Umformtechnik GMBH & Co. KG #20,723 · 13 patents
- Aroma System S.R.L. #20,724 · 13 patents
- Arrien Pharmaceuticals LLC #20,725 · 13 patents
- Artskills, Inc. #20,727 · 13 patents
- ASM Assembly Systems Singapore PTE. Ltd. #20,728 · 13 patents
- Asset Guard Products Inc. #20,729 · 13 patents
- Atec International Team Co., Ltd. #20,730 · 13 patents
Leaders in H03K (Pulse Technique)
Other assignees with the most granted patents in Artery's primary technology class.
- Texas Instruments Incorporated 1,140 in class
- Taiwan Semiconductor Manufacturing Company Ltd. 762 in class
- SK hynix Inc. 699 in class
- Qualcomm Incorporated 614 in class
- Intel Corporation 607 in class
- Micron Technology, Inc. 537 in class
- Infineon Technologies AG 419 in class
- Semiconductor Energy Laboratory Co., Ltd. 389 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Artery, neither rank-band nor same-CPC leaders (those blocks stay above). In H03K (Pulse Technique), Artery ranks #297 of 1,682 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (34 here).
Artery's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 45th percentile higher than 45% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 7 | 53.8% |
| 2021 | 1 | 7.7% |
| 2022 | 3 | 23.1% |
| 2024 | 1 | 7.7% |
| 2025partial year | 1 | 7.7% |
Which technologies does Artery Technology Company patent most?
Top 14 of 14 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Artery Technology Company's patent record in context - here's where to go next.
- Artery Technology Company's lead technology class is H03K (Pulse Technique), 61.5% of its portfolio - see every assignee active in that class. Explore H03K
- Ranked #20,767 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Artery Technology Company against Armo Biosciences, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.